$2.68
-0.04-1.47%
Ult. Agg.: Oct 21, 9:17 AM
$2.80
0.082.94%
BridgeBio Oncology (BBOT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.54 | $-0.51 | $-0.66 | $-0.37 |
| Actual | $-705.20 | $-526.11 | $-0.49 | $-1.03 |
| Surprise | -130492.6% | -103058.8% | +25.8% | -178.4% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.66 | $-0.63 | $-0.64 | $-0.67 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $-705.20 | $-0.54 | -130492.6 % |
| Q1 | May 12, 2026 | $-526.11 | $-0.51 | -103058.8 % |
| Q4 | Mar 5, 2026 | $-0.49 | $-0.66 | 25.8 % |
| Q3 | Nov 12, 2025 | $-1.03 | $-0.37 | -178.4 % |